which has worse side effects semaglutide or tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Comparative safety and side effects

Semaglutide is not recommended during breastfeeding, so this question is hypothetical rather than clinical guidance

4 Conclusions and Future Directions This review considers the current evidence on whether drugs used to treat diabetes mellitus could have potential as therapies to prevent or reverse the loss of muscle strength and mass that characterises sarcopenia

The medications now included in this MDL are Ozempic, Wegovy, Rybelsus (also manufactured by Novo Nordisk), Mounjaro, and Trulicity (both of which are manufactured by Eli Lilly and Company)

As it is used to help treat diabetes and balance blood sugar levels, Ozempic generally comes in lower doses than Wegovy

Realistic Expectations Learn why every patients timeline is unique and why treatment decisions should always remain individualized